News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Roche (RHHBY) Makes $5.7 Billion Hostile Bid for Diagnostic Company Illumina, Inc. (ILMN)


1/25/2012 7:15:13 AM

The President and CEO of U.S. gene sequencing device maker Illumina Inc said he had no comment to make about a $5.7 billion cash takeover offer for the company by Swiss drugmaker Roche Holding AG's. "We have no comment at this time," Jay Flatley said in an email to Reuters. Roche, the world's largest maker of cancer drugs, said it would offer to acquire all shares of Illumina for $44.50 per share in cash, an 18 percent premium to Illumina's Tuesday close price of $37.68 on the Nasdaq.

Read at Reuters
Read at Washington Post
Read at Forbes
Read at SF Gate
Read at BusinessWeek
Read at Financial Times

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES